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Abstract
Background: Variation in the human fecal microbiota has previously been associated with body mass index (BMI).
Although obesity is a global health burden, the accumulation of abdominal visceral fat is the specific cardio-metabolic
disease risk factor. Here, we explore links between the fecal microbiota and abdominal adiposity using body
composition as measured by dual-energy X-ray absorptiometry in a large sample of twins from the TwinsUK cohort,
comparing fecal 16S rRNA diversity profiles with six adiposity measures.
Results: We profile six adiposity measures in 3666 twins and estimate their heritability, finding novel evidence for
strong genetic effects underlying visceral fat and android/gynoid ratio. We confirm the association of lower diversity of
the fecal microbiome with obesity and adiposity measures, and then compare the association between fecal microbial
composition and the adiposity phenotypes in a discovery subsample of twins. We identify associations between the
relative abundances of fecal microbial operational taxonomic units (OTUs) and abdominal adiposity measures. Most
of these results involve visceral fat associations, with the strongest associations between visceral fat and Oscillospira
members. Using BMI as a surrogate phenotype, we pursue replication in independent samples from three
population-based cohorts including American Gut, Flemish Gut Flora Project and the extended TwinsUK cohort.
Meta-analyses across the replication samples indicate that 8 OTUs replicate at a stringent threshold across
all cohorts, while 49 OTUs achieve nominal significance in at least one replication sample. Heritability analysis of the
adiposity-associated microbial OTUs prompted us to assess host genetic-microbe interactions at obesity-associated
human candidate loci. We observe significant associations of adiposity-OTU abundances with host genetic variants in
the FHIT, TDRG1 and ELAVL4 genes, suggesting a potential role for host genes to mediate the link between the fecal
microbiome and obesity.
Conclusions: Our results provide novel insights into the role of the fecal microbiota in cardio-metabolic disease with
clear potential for prevention and novel therapies.
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Background
Obesity has rapidly become a global public health prob-
lem, with obesity-related disease now one of the leading
causes of preventable death worldwide [1]. Although
overall obesity poses a global health epidemic, it is the
accumulation of excess abdominal fat that is a critical
risk factor for cardiovascular and metabolic disease [2].
Changes in diet and a sedentary lifestyle can partly ex-
plain the rise in obesity, and family and twin studies also
show a genetic influence, with obesity heritability esti-
mates of 0.60–0.70 [3–6]. Genome-wide association
studies (GWASs) have identified genetic risk factors
[7–9], but genetic variants detected to date explain
less than 3 % of the heritability of obesity, with a pre-
diction ability of up to 20 %, suggesting a role for
other mechanisms [10].
Recent insights show that the gut microbiota may play
a crucial role in obesity and cardio-metabolic disease
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risk. Many studies have linked different aspects of the
fecal microbiome to obesity [11–17]. However, in most
cases the causal mechanisms leading to these associa-
tions are unclear, although several theories have been
suggested, including alterations in energy harvest from
food [18] and an increase in potential inflammatory
microbes [19]. There are also inconsistencies in the taxa
associated with obesity [16] that may be explained in
part by study design differences such as control of diet
and sequencing platforms, but could also be due to dif-
ferences in collective bacterial gene function rather than
the species community composition [20]. Another compli-
cating factor that varies among studies is the quantifica-
tion of obesity. While most human studies consider body
mass index (BMI) as the measure of obesity [11, 21, 22],
mouse studies typically use epididymal fat weight [23] or
dual-energy X-ray absorptiometry (DXA)-derived mea-
sures of total body fat [18, 24]. BMI is an imprecise meas-
ure of adiposity and measures overall mass without
distinction between lean and fat mass [25]. Estimates of
visceral fat, however, have stronger associations with
obesity-related cardio-metabolic diseases, such as type 2
diabetes and cardiovascular disease [26–28], but have typ-
ically been difficult to measure in humans and have yet to
be linked with variation in the human fecal microbiome.
Previous studies have attempted to tackle heritability
of attributes of the microbiome. Zoetendal et al. [29]
found that monozygotic (MZ) twins had more similar
microbiomes than marital partners or unrelated individ-
uals, suggesting either a role for host genotype in gut
microbiome colonisation or mother-to-child transmission
of microbes. In addition, a study of Methanobrevibacter
carriage concordance rate in twins showed higher con-
cordance in MZ twins [30]. A recent study by Goodrich et
al. [31] was the first large-scale analysis to report heritabil-
ity of the human fecal microbiota, with the relative abun-
dance of 16S rRNA gene sequences belonging to the
family Christensenellaceae showing the most variance
attributed to host genetic effects. Christensenellaceae was
also enriched in abundance in the microbiomes of low-
BMI individuals. Here, we build upon these findings to
explore the association between the human fecal micro-
biome and abdominal adiposity as the main risk factor for
cardio-metabolic disease risk. We obtained DXA-based
measures of abdominal adiposity, specifically, visceral fat
mass, subcutaneous fat mass and previously reported
trunk fat measures [32], as well as body fat distribution, in
a larger dataset of twins, including a subset of the twin
sample profiled by Goodrich et al. [33] and a subset of the
twin sample profiled by Jackson et al. [34]. We show
that heritable components of the human fecal micro-
biome [31, 33] are significantly associated with vis-
ceral fat, confirming the key role of the microbiome
in cardio-metabolic disease risk. We further identify a
link between fecal microbiome profiles, visceral fat
and subcutaneous fat with genetic variants in obesity
candidate genes, providing potential insights into
mechanisms to relate the fecal microbiome to cardio-
metabolic disease risk.
Results
Measures of adiposity were obtained from an unselected
sample of 3666 predominantly female twins from the
TwinsUK cohort (TUK-D), which included 1044 MZ
and 789 dizygotic (DZ) twin pairs (average age 63 years
(range 32–87); 96.4 % female). Fecal microbiome profiles
were available for 1313 of these individuals (496 MZ, 594
DZ and 223 unrelated individuals; average age 63 years
(range 32–87); 96.4 % female). The demographics for
these samples can be found in Table 1 and Additional
file 1: Table S7. Fecal microbiome profiles included 601
previously published profiles from Goodrich et al. [33], an
additional 671 profiles recently reported within Jackson et
al. [34] and 41 additional twin profiles [33]. All fecal sam-
ples underwent 16S rRNA profiling (V4 region) gene se-
quencing on the Illumina MiSeq platform, providing 2135
operational taxonomic units (OTUs) at 97 % sequence
identity.
Adiposity and visceral fat heritability
We studied six adiposity measures in total, and these in-
cluded three measures of abdominal adiposity (visceral fat
mass (VFM), subcutaneous fat mass (SFM), percentage
trunk fat (pTF)), two measures of body fat distribution
(android/gynoid ratio (AGR) and waist/hip ratio (WHR))
Table 1 Description of the TwinsUK discovery sample
Full dataseta Microbiome subsetb








Age (mean (range)) 63 (32–87) 63 (32–87)





aSummaries are shown for both the extended dataset of 3666 twins used in
the phenotype heritability analyses and for the microbiome sample subset of
1313 individuals. bAdditional file 1: Table S7 includes extended descriptions of
the microbiome data subset
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and one measure of overall obesity, BMI. Adiposity was
estimated using DXA-derived measures, which have been
shown to be reliable alternatives [35–38] to traditional
computed tomography (CT) and magnetic resonance im-
aging scan-based measures of adiposity. The majority of
these adiposity measures have been previously explored in
the TwinsUK cohort; however, VFM and AGR are newly
obtained phenotypes. The new measure of VFM was
highly correlated with other abdominal and overall adipos-
ity measures, including BMI (Fig. 1a). Twin-based herit-
ability analysis of VFM showed evidence of a significant
additive genetic component, or heritability (h2), contribut-
ing to 0.70 (95 % CI = 0.58–0.74) of the total variance in
VFM. The VFM heritability estimate remained high after
adjustment for BMI (0.64, see Additional file 2). We
obtained comparable estimates for the heritability of SFM
(h2 = 0.72 (95 % CI = 0.60–0.77)), pTF (h2 = 0.66 (95 %
CI = 0.55–0.77), AGR (h2 = 0.65 (95 % CI = 0.55–0.76)),
BMI (h2 = 0.75 (95 % CI = 0.68–0.80) and a slightly lower
estimate for WHR (h2 = 0.32 (95 % CI = 0.24–0.40)), in
line with previous studies [39–41] (Fig. 1b).
The twin fecal microbiome and its heritability
The human fecal microbiome in the dataset of 1313
twins comprised Firmicutes as the most dominant
phylum (51 %), followed by Bacteroidetes (39 %) and
Proteobacteria (4 %). These estimates are comparable
to previously published results [33] and reflect a typ-
ical Western fecal microbiome. Using twins, we then
explored evidence for heritability in the gut microbial
profiles (relative abundances of OTUs), extending the
results of Goodrich et al. [33] in the larger sample of
1313 twins using the same methods for OTU herit-
ability. Altogether, OTU heritability in this dataset
ranged between 0 and 0.42, and the average estimate
over all OTUs was 0.07. The most heritable microbe was
an OTU classified as Clostridium perfringens (h2 = 0.42
(95 % CI 0.23–0.51)) (Additional file 1: Table S1). The
family Christensenellaceae was the most heritable family
reported in Goodrich et al. [33], and while OTUs
representing Christensenella were not the top ranked
in this larger dataset, Christensenella OTU heritability
remained high with one OTU, Greengenes OTU
176318, showing a heritability of 0.31 (95 % CI 0.21–0.41).
The microbial heritability estimates presented here are
overall consistent with the original microbial twin-based
heritability findings from Goodrich et al. [31] and with re-
cent extended heritability estimates from the extended
TwinsUK cohort [33]. For example, at the genus level,
heritability estimates across studies show a correlation
of 0.67 between this TUK-D dataset and the results
in Goodrich et al. [31] (Additional file 3: Figure A)
and 0.77 between TUK-D and Goodrich et al. [33]
(Additional file 3: Figure B). Approximately 6 % of
the dataset (122 OTUs) had evidence for at least
moderate heritability (h2 > 0.2), and these were
present in at least 25 % of individuals (Additional









































































Fig. 1 Distribution and heritability of adiposity phenotypes. a Scatterplot matrix showing the distribution and correlation between six adiposity
measures in 3666 twins. The distribution of each phenotype (prior to normalisation) is shown along the diagonal. The lower panel shows scatterplots
for each pair of adiposity phenotypes, and the upper panel denotes the coefficients of determination. b Heritability of six adiposity measures in the
TwinsUK cohort, as well as visceral fat measures in three independent cohorts: Framingham [39], Quebec [41] and Heritage [40]. The total variance of
each adiposity phenotype is decomposed into variance components attributed to additive genetics (A) or narrow-sense heritability (h2), common
environment (C) and unique environment (E)
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Fecal microbiome diversity is strongly linked to obesity
and central adiposity
Microbial diversity (alpha diversity) in obese individuals
has been reported to be lower than that of lean individuals
[15, 31]. Here we compared estimates of Shannon diver-
sity for the subjects’ fecal microbiomes with all adiposity
measures using a linear mixed effects model, adjusting for
diet (see Methods), age, sex and family relatedness. As in
previous reports [15, 31, 42], we observed a significant
negative association between Shannon diversity and all
adiposity phenotypes (Fig. 2, Additional file 4). VFM
showed the most significant association with alpha diver-
sity (beta = −0.14, se = 0.27, P = 4.13 × 10−7) and WHR
showed the least significant association (beta = −0.05,
se = 0.031, P = 0.097). All measures but WHR were signifi-
cantly associated with diversity; therefore, alpha diversity
measures in our sample are not only negatively associated
with obesity but are also significantly lower in individuals
with greater abdominal adiposity and visceral fat.
Fecal microbiome profiles associate with central adiposity
across twins
We investigated the association of each OTU with all
adiposity traits, including BMI, across individuals. Of the
approximately 12,000 OTU-phenotype associations consid-
ered, 3217 were nominally significant, and 149 OTU re-
sults surpassed the Bonferroni correction (P = 3.90 × 10−6).
The 149 significant microbial-adiposity associations in-
volved 97 unique OTUs (Additional file 1: Table S2), and
these fell within either the Firmicutes or Bacteroidetes
phylum, and most within the Ruminococcaceae family.
Visceral fat (VFM) associations made up the highest pro-
portion of significant results surpassing the Bonferroni
threshold (45 %, Fig. 3a). The peak result was an OTU
classified as Oscillospira (Greengenes OTU 372146),
which was associated with VFM (P = 1.93 × 10−12).
Ruminococcaceae OTUs featured prominently in the top
significant results, along with a number of other OTUs
within the Lachnospiraceae family. Given the importance
of VFM and AGR in cardiovascular risk, we were inter-
ested in determining potential microbial markers of car-
diovascular risk. OTUs within Oscillospira, Lachnospira
and Ruminococcus all showed negative associations with
VFM and AGR, suggesting a potential protective role for
these bacteria in cardiovascular risk (Fig. 3, Additional
file 1: Table S2). Blautia OTUs showed a positive as-
sociation with VFM and AGR and may be a microbial
marker candidate for cardiovascular risk (Fig. 3a, Additional
file 1: Table S2). These results support the crucial role of
the microbiome towards visceral fat as a marker of adipos-
ity and cardio-metabolic disease risk.
Due to the large number of OTUs in the top-ranked as-
sociation results belonging to the same genera and families,
we also explored the peak results with respect to collapsed
taxonomies, whereby we combined sequences from OTUs
with the same taxonomy. We first tested the association
between the 8 genera, to which the 97 adiposity-significant
OTUs were assigned, and adiposity. Altogether, 11 associa-
tions passed Bonferroni correction (P = 0.001), and 27
genus-adiposity associations were nominally significant.
These comprised 6 of the genera and included Blautia,
Oscillospira, Lachnospira, Ruminococcus (within both
Lachnospiraceae and Ruminococcaceae) and Clostridium.
The two most significant associations were obtained be-
tween Oscillospira and VFM (P = 3.29 × 10−07, Additional
file 1: Table S3) and Blautia and VFM (P = 3.65 × 10−06).
We considered a similar approach at the family level where
the most significant bacterial-adiposity association was a
Fig. 2 Alpha diversity of the fecal microbiome in individuals with high and low fat content. For each phenotype, individuals who were more
than 1.5 standard deviations from the mean of the phenotype were assigned to high and low phenotype groups respectively. Alpha diversity
measures (using Shannon diversity) were compared between the high and low phenotype groups (Wilcoxon test * = 0.05 ** = 0.001 *** = 0.0001)
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negative relationship between Christensenellaceae and
VFM (P = 1.48 × 10−10), supporting prior findings from
Goodrich et al. [31].
We then explored fecal microbiome associations with
obesity within a subsample of 247 MZ twin pairs to
identify potential environmental or stochastic effects.
MZ twins are matched for sex and age, and have nearly
identical genomes and very similar early life environ-
ments. Therefore, microbiome differences observed
within MZ twin pairs are likely to be a result of environ-
mental and stochastic influences or effects that are sec-
ondary to the phenotype. We estimated differences in
fecal OTU relative abundances within 247 MZ twin
pairs and compared these to differences in adiposity, for
each of the six adiposity phenotypes using a Pearson
correlation. Although no results surpassed Bonferroni
significance for multiple testing across the six pheno-
types, potentially in part due to the smaller sample size,
many of the observed effects were consistent with those ob-
served across 1313 individuals (Additional file 1: Table S2).
The peak association in MZ twin pairs was observed
between an unknown Clostridiales OTU (Greengenes
OTU 331113) and AGR (Pearson coefficient = −0.24,
P = 9.68 × 10−05).
We performed two additional follow-up analyses of
the association between fecal microbiome OTUs and
adiposity phenotypes. Because of the high correlation
across multiple obesity measures, we explored the asso-
ciation between fecal microbiome OTUs and adiposity
measures independent of BMI. Following adjustment for
BMI, 133 of the 149 significant associations remained
nominally significant with the same direction of effect
(Additional file 1: Table S2). Because of the strong asso-
ciation that we observed between alpha diversity and
adiposity, we also wanted to assess if the strongest
adiposity-OTU associations were with OTUs that were
markers of diversity, or whether these taxa associated
with adiposity were independent of species richness. To
this end we repeated the adiposity-OTU analyses at the
149 significant OTU-phenotype associations now includ-
ing alpha diversity as a covariate in the linear model as
previously described [34]. All of the reported significant
associations remained nominally significant after adjust-
ment for alpha diversity.
Replication of microbial-obesity associations
We pursued replication of the 97 significant OTUs asso-
ciated with visceral fat in 4286 independent samples
from three additional population-based replication sam-
ples, including samples from the American Gut, Flemish
Gut Flora Project (FGFP) and extended TwinsUK co-
horts. Due to the lack of cohorts with both visceral fat
measurements and gut microbiome data available, BMI
was used as a surrogate phenotype for visceral fat in
these analyses. In each replication cohort, individuals se-
lected were of European descent, over the age of 20, and
had a BMI ranging between 18.5 and 30 units, resulting
in 2338 individuals from the American Gut cohort
(USA), 917 individuals from the FGFP cohort (Belgium)
and 1031 individuals from the extended TwinsUK
cohort (UK) who were not included in the discovery
TwinsUK sample. To account for the difference between
the 16S rRNA gene sequences between the TwinsUK
discovery sample and the replication datasets, OTUs in
each replication dataset were picked using closed refer-
ence in the software Quantitative Insights Into Microbial
Ecology (QIIME) [43] at 97 % using UCLUST [44] against
the representative sequences for the 97 Bonferroni-
b
a
Fig. 3 Associations between fecal microbiome 16S OTUs and
visceral fat in the TwinsUK and replication datasets. a The inner circle
denotes the phylogenetic tree of OTUs, produced using iTOL [93]
based on Greengenes May 2013 tree filtered for the OTUs in the sample.
Tree leaves are coloured according to the direction of association with
visceral fat, where blue indicates a negative association, while red
indicates a positive association. The outer circle denotes the significance
of each OTU-visceral fat association, where P values are plotted as –log10
(P value), and the red line shows the Bonferroni significance threshold.
The figure highlights the most-associated OTU in the sample (OTU
372146), as well as the two closed-reference OTUs that were significantly
associated with host genetic variants in genes FHIT (OTU 181702) and
ELAVL4 (194733). It also highlights the heritable Christensenellaceae OTU
176318. The figure also denotes the tree branches containing members
of Clostridiales, Bacteroides and Christensenellaceae to accompany results
and discussion in the main text. b Forest plot of beta coefficients
with confidence intervals of eight OTUs that replicated robustly in
a meta-analysis of three independent cohorts (TUK-R, AG and FGFP)
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significant OTUs associated with adiposity measures, to
maximize similarity in datasets during replication. Further
processing and downstream analyses took into account
technical and lifestyle cohort-specific covariates to match
as closely as possible the discovery sample and account
for differences across cohorts (see Methods).
The 97 OTU-BMI associations were tested within each
replication sample (Additional file 5), and the results were
combined in a meta-analysis across the three replication
samples (Additional file 1: Table S4). At a stringent
Bonferroni significance threshold (P = 0.05/97), 8 OTUs
robustly replicated with the same direction of effect across
the three replication cohorts (Fig. 3b, Additional file 1:
Table S4), excluding results with evidence for heterogen-
eity. Furthermore, 13 OTUs showed evidence for associ-
ation with BMI that was stronger in the meta-analysis
across all four population-based cohorts, compared to the
discovery TwinsUK sample alone (Additional file 1:
Table S4). At a more relaxed significance threshold
(nominal significance and same direction of effect in
at least 1 cohort), 49 OTUs showed the same direc-
tion of effect and nominally significant evidence for
association with BMI in at least one of the replication
samples (Additional file 1: Table S4). The 8 OTUs
with robust evidence for replication included mem-
bers of Lachnospiraceae and Ruminococcaceae, while
the 49 OTUs included not just members of the
Lachnospiraceae and Ruminococcaceae families, but also
of Christensenellaceae, Clostridiales, Bacteroidaceae and
Rikenellaceae.
Microbial functional alterations in obesity
Given the strong associations observed between fecal
microbiome variation and obesity phenotypes, we next
wished to assess potential functional differences that
may be the result of a fecal microbiome dysbiosis in
obesity. To this end, we aimed to infer KEGG functions
of the fecal microbes by using the software Phylogenetic
Investigation of Communities by Reconstruction of
Unobserved States (PICRUSt) to predict metagenomes
for each sample based on the closed-reference 16S rRNA
gene sequences. The PICRUSt analyses resulted in
altogether 233 Kyoto Encyclopedia of Genes and Ge-
nomes (KEGG) pathways and 6909 KEGG orthologies
(KOs) within our sample. We next aimed to determine
the relationship between the inferred KEGG functions
and adiposity. We adjusted the KEGG pathway scores
obtained for each individual in our sample for technical
covariates (see Methods) and performed association ana-
lyses of these functions with the adiposity measures
using a linear mixed effects model as previously de-
scribed. We also assessed KO differential abundance in
high and low visceral fat individuals using Statistical
Analysis of Metagenomic Profiles (STAMP) [45].
Of the 233 KEGG pathway associations with six adi-
posity measures, 13 associations surpassed Bonferroni
correction (P = 3.6 × 10−5), and 218 associations were
significant after false discovery rate (FDR) correction
(FDR 5 %). Four of the 13 Bonferroni-significant associa-
tions were with KEGG functions related to metabolism,
as well as 98 of the FDR 5 % significant results (Fig. 4a).
Functions within carbohydrate metabolism were posi-
tively associated with adiposity, in particular, glyoxylate
and dicarboxylate metabolism, which had a Bonferroni-
significant association with VFM (P = 1.19 × 10−06) and
FDR 5 % significant associations with the remaining adi-
posity measures. Five groups within the glyoxylate and
dicarboxylate metabolism pathway were significantly dif-
ferentially abundant in high visceral fat and low visceral
fat individuals (Fig. 4b). Two of these five groups
remained significant following Bonferroni correction,
and these were K03779 (ttdA, Q = 2.87 × 10−3) and
K03780 (ttdB, Q = 1.79 × 10−3); both increased in sub-
jects with high visceral fat. The remaining 3 pathways
that surpassed Bonferroni correction were obtained be-
tween pTF and dioxin degradation, prenyltransferases
and N-glycan biosynthesis.
Host genetic influences on microbiome-obesity
associations
Twin-based heritability estimates supported a strong
genetic component for visceral fat, and our heritability
analyses of the fecal microbiome in this sample showed
wide variability in heritability between fecal microbial
taxa (0–0.42), with members of Firmicutes and Actino-
bacteria being most heritable. The average heritability of
the overall fecal microbiome sample was 0.07, while the
average shared environment component was 0.046 and
the average unique environment was 0.93. The peak 97
Bonferroni-significant OTUs associated with abdominal
adiposity in our sample had a median heritability of 0.16
and an average OTU heritability of 0.16. The average her-
itability of the 97 adiposity-associated OTUs was signifi-
cantly greater than the overall average heritability over all
OTUs at 0.07 (Wilcoxon rank test, P = < 2.2 × 10−16). In
addition the average unique environmental compo-
nent of the 97 is significantly lower than the overall
average for all OTUs (0.79 versus 0.93, Wilcoxon rank
test, P < 2.2 × 10−16). These estimates suggest host genetics
impacts both the fecal microbiome and adiposity.
To explore the hypothesis that host genetics may in-
fluence the observed microbial-adiposity associations,
we performed candidate gene analysis comparing host
genetic variants at human obesity candidate loci with
the adiposity-associated fecal microbiome profiles. We
selected single nucleotide polymorphisms (SNPs) within
human loci previously associated with obesity as re-
ported by Locke et al. [8], using common genetic
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variants within 97 50-kb regions, centred around the
peak BMI-associated GWAS SNP in each region. At a
Bonferroni-corrected P-value threshold (P = 5.31 × 10−06)
taking into account the total number of genomic regions
and adiposity OTUs considered, OTU associations with
genetic variants in three genomic regions surpassed
multiple testing. The strongest association between
host genotype and adiposity-associated OTUs was ob-
served between an OTU within the Clostridiales order
(Greengenes OTU 181702) and a host genetic variant
within an intron of the FHIT gene (rs74331972 with
OTU 181702, P = 2.49 × 10−06, Fig. 5a). FHIT encodes
the fragile histidine triad protein and is a tumour
suppressor gene that has been linked to cancers of
the digestive tract. Although the most significant FHIT as-
sociation was obtained with OTU 181702 (h2 = 0.13),
which we identified as significantly associated with SFM
and VFM (P = 1.18 × 10−06 and 1.27 × 10−06 respectively),
the same genetic variant was also associated with another
VFM- and SFM-associated OTU (rs74331972 with OTU
287790, P = 5.38 × 10−05). The second ranked significant
genetic association was obtained between variants near
gene TDRG1 (peak SNP rs1433723, P = 4.32 × 10−06) with
an open reference unknown Clostridiales OTU (h2 = 0.14),
a
b
VFAT SFM PTF BMI WHR AGR
Fig. 4 Microbial functional analysis in obesity. a Microbial PICRUSt-predicted KEGG functions relevant to metabolism in the twin dataset, and their
association with the six adiposity measures. The heatmap denotes the direction of association between each microbial PICRUSt-predicted KEGG
function and adiposity measures, where blue indicates a negative association, while red indicates a positive association. Bonferroni-significant
associations are highlighted (*). b Five KO genes that are differentially abundant between high and low visceral fat individuals in glyoxylate and
dicarboxylate metabolism, as tested by a two-sided Welch’s t test. FDR-adjusted P values are reported at the right of the image, and stars indicate
Bonferroni-significant associations. Figure was produced using STAMP [45]
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which we had identified as significantly associated with
VFM (P = 4.97 × 10−07, Fig. 5b). The final significant gen-
etic association was observed at a variant in an intron of
the gene ELAVL4 (rs2480677, P = 4.95 × 10−06, Fig. 5c)
with an unknown Blautia OTU, 194733 (h2 = 0.02), which
we had identified as significantly associated with
VFM (P = 1.27 × 10−07), SFM (P = 2.26 × 10−06) and
AGR (P = 3.11 × 10−07) in the peak 149 adiposity-OTU
results. When we considered the genetic-OTU association
results at a less conservative significance threshold
(P = 5 × 10−4), there were in total 412 suggestive OTU-
genetic associations located within or near 48 unique
genes, including obesity genes such as FTO, RPTOR and
TMEM18.
Fig. 5 Peak genetic associations between obesity human genetic variants and adiposity-associated OTUs in the twin fecal microbiome. a Association
between OTU 181702 and FHIT SNP rs74331972. The boxplot indicates change in OTU 181702 abundance with genotype at SNP rs74331972. The
LocusZoom plot denotes the strength of association of OTU 181702 with SNP rs74331972, as well as the SNPs in the surrounding region. b Association
between open reference OTU 25576 and TDRG1 SNP rs1433723. The boxplot indicates change in open reference OTU 25576 abundance with genotype
at SNP rs1433723. The LocusZoom plot denotes the strength of association of open reference OTU 25576 with SNP rs1433723, as well as the SNPs in
the surrounding region. c Association between OTU 194733 and ELAVL4 SNP rs2480677. The boxplot indicates change in OTU 194733 abundance with
genotype at SNP rs2480677. The LocusZoom plot denotes the strength of association of OTU 194733 with SNP rs2480677, as well as the SNPs in the
surrounding region. SNPs in all LocusZoom plots are coloured according to their strength of linkage disequilibrium with the peak SNP plotted
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Functional characterization of host genetic variants
associated with adiposity-OTU markers in the gut
We next focused on the three significant host genetic as-
sociations in FHIT, TDRG1 and ELAVL4 with adiposity-
associated OTUs. The transcriptomic profiles for these
genes from the Genotype-Tissue Expression (GTEx) re-
source [46] indicated that all three genes are expressed
in tissues that form part of the gastrointestinal tract. FHIT
is expressed across a wide range of tissues, including
stomach, colon (transverse and sigmoid), small intestine
(terminal ileum), oesophagus (muscularis and mucosa)
and oesophagus-gastro-oesophageal junction. TDRG1 is
expressed at highest levels in testis, in multiple brain tis-
sues, as well as oesophagus (mucosa), while ELAVL4 is
expressed at highest levels in multiple brain tissues, testis,
pituitary gland, colon (sigmoid and transverse), pancreas,
small intestine (terminal ileum), oesophagus (muscularis)
and oesophagus-gastro-oesophageal junction.
We next explored the functional impact of the SNPs
in these three genes that we identified as most signifi-
cantly associated with adiposity-related fecal OTUs. The
GTEx expression quantitative trait locus (eQTL) analysis
results indicate that rs1433723 in TDRG1 is an eQTL
for TDRG1 expression specifically in oesophagus mucosa
in the GTEx dataset. We then tested the associations of
this variant on TDRG1 gene expression and DNA
methylation levels in adipose biopsies available for 542
individuals from the TwinsUK cohort [47, 48]. We found
that rs1433723 also is significantly associated with DNA
methylation levels in TDRG1 (peak association: rs1433723
with TDRG1 cg10553343, P = 1.53 × 10–17; Additional
file 1: Table S5), but not with gene expression profiles in
these samples in adipose tissue [47]. The remaining two
associated SNPs with adiposity OTUs (rs74331972 in
FHIT and rs2480677 in ELAVL4) were not associated with
the corresponding gene’s expression levels in GTEx across
multiple tissues. However, both variants showed modest
effects on DNA methylation levels in adipose tissue
(rs74331972 on FHIT cg15570148, P = 3.4 × 10−4; and
rs2480677 on ELAVL4 cg00322486, P = 1.4 × 10−3), but
not on gene expression profiles in adipose tissue in our
dataset.
Discussion
Here, in the largest microbiota-obesity study to date
using detailed adiposity and visceral fat measures, we
have shown that fecal microbial diversity and specific
members of the human fecal microbiota are strongly
associated with obesity-related phenotypes, specifically
abdominal adiposity. The majority of microbial associa-
tions were obtained with visceral fat, a key metabolic
disease risk factor, which we also show is strongly herit-
able in our extended sample of more than 3000 twins. In
addition to obtaining novel heritability estimates for
visceral fat, we show that android/gynoid ratio is highly
heritable in this same cohort, and confirm high herit-
ability estimates for the remaining adiposity phenotypes.
Using BMI as a measure of obesity, we robustly replicate
eight obesity-associated fecal microbes in three inde-
pendent samples from the American Gut, FGFP and
extended TwinsUK dataset. We also demonstrate that
host genes have an effect on components of the fecal
microbiota, including the 97 adiposity-associated OTUs,
although the mechanism remains unclear. Given the im-
pact of host genetics on both obesity and fecal microbes,
and our findings of strong association between adiposity
and fecal microbiome variation, our results therefore
support the hypothesis that heritable microbes play a
role in determining components of obesity relevant to
cardio-metabolic disease and may be one potential
source contributing to missing heritability in obesity.
Heritability and importance of visceral fat
Visceral fat, the type of adipose tissue with the most im-
portant implications for metabolic health [2], was highly
heritable (0.70) and showed the most significant associa-
tions with the fecal microbiota. Previous studies, for
example, from the Framingham [39], Quebec [41] and
Heritage [40] family-based cohorts, used CT scans to es-
timate visceral adiposity and found heritability estimates
of visceral fat to be between 0.36 and 0.55, which is
lower but comparable to our estimates in twins. Given
the strong correlation between multiple adiposity pheno-
types, we sought to assess if the high heritability ob-
served in visceral fat is due to high heritability of BMI.
Heritability of visceral fat remained high after adjust-
ment for BMI (0.64, see Additional file 2), suggesting
that the high heritability we report here for VFM is inde-
pendent of its association with BMI.
Several microbiome studies have linked increased
overall abdominal adiposity, for example, using body fat
distribution measures such as waist/hip ratio, to fecal
microbiome profiles [15, 49]. However, although specific
probiotic intake has been reported to lower visceral fat
[50], to date there has not yet been a systematic com-
parison of visceral fat and variation in the fecal micro-
biome across human subjects. Our results are therefore
the first, to our knowledge, to link visceral fat with
changes in the fecal microbiota variation in humans.
The findings suggest that visceral fat mass is more im-
portant for differences in the obese microbiome, rather
than overall body mass. This is also demonstrated in the
recent Clarke et al. study [51], where elite rugby union
players, who due to their greater muscle mass were de-
fined as overweight and obese (BMI = 29 ± 3), had a
more diverse microbiota than those of both low BMI
and high BMI controls. We also report a novel android/
gynoid ratio heritability estimate of 0.65, higher than
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previous family-based estimates of 0.43 [52]. Android/
gynoid ratio, like visceral fat, is also a risk factor for
cardio-metabolic disease, and accordingly our results
show consistent direction of association effects for
OTUs associated with both phenotypes.
Visceral fat has widespread associations with the human
fecal microbiome
Due to its importance in cardio-metabolic disease risk,
direct measures of visceral fat are much more inform-
ative than BMI in assessing the metabolic consequences
of obesity. Most microbiome obesity studies to date have
used BMI as a biomarker, with some mouse studies
using epididymal fat. We therefore present a novel dual
approach, using visceral fat to find novel metabolic asso-
ciations in a sample of twins, and BMI to confirm asso-
ciations across independent samples. The power of this
design was apparent in the number of peak associations
observed with visceral fat. All of the reported adiposity
OTUs reported in this study were significantly associ-
ated with visceral fat, while only 7 of these OTUs were
significantly associated with BMI, suggesting that micro-
bial studies that only use BMI as a measurement of
obesity may be limited.
Altogether, we identified 97 OTUs that were strongly
significantly associated with the adiposity phenotypes,
and all of these were significantly associated with visceral
fat. Although the 97 OTUs were not the most abundant
OTUs within the gut, OTUs within the Firmicutes
phylum showed the most significant adiposity associa-
tions, perhaps in part reflecting the dominant frequency
of Firmicutes in the human gut. However, the direction
of association differed for different genera within the
Firmicutes. For example, Oscillospira OTUs often
showed protective associations with VFM, while Blautia
OTUs commonly showed adverse associations that could
be used as potential markers of cardiovascular risk. Our
findings also confirm the importance of fecal micro-
biome diversity in obesity, as we are able to replicate
strong association between adiposity phenotypes and
alpha diversity. Furthermore, the majority of the ob-
served 97 VFM associations are independent of alpha di-
versity and BMI, suggesting that the OTUs significant in
this analysis are not just markers of diversity, but form
real associations with adiposity and cardio-metabolic
disease risk.
To explore the factors underlying the variation in the
97 adiposity-associated OTUs, we used twin modelling
and determined that these 97 OTUs showed significantly
greater average heritability (0.16) compared to all OTUs
in the larger dataset. The average shared environment
component was also higher, but the average unique
environment component was lower than the overall
dataset average. We therefore infer that host genetics in
particular, as well as early shared environmental factors,
play an important role in the variation of obesity-
associated microbes. However, although the estimate
(including measurement error) is approximately 0.80,
the average unique environment component in the 97
OTUs was lower than the overall dataset average. This is
consistent with findings from previous work [31] that en-
vironmental factors are key drivers of the microbiome,
and they strongly contribute to variation at the obesity-
microbiome associations.
As our results consisted of OTU associations within the
same families and genera of bacteria, we also explored
associations of adiposity at the collapsed taxonomic level
(family and genus) for the top OTU associations.
Lachnospiraceae and Ruminococcaceae continue to dis-
play opposing directions of effect at the family level. We
also see that the heritable family Christensenellaceae is
strongly associated with visceral fat, as previously reported
for BMI in Goodrich et al. [31]. Christensenellaceae was
previously found to be protective of obesity both in mice
and in human twins in our previous work [31]. We extend
the findings here, showing strong protective associations
between Christensenellaceae and visceral fat, in particular
suggesting that individuals with Christensenellaceae have
less cardiovascular risk than those without. Further work
to elucidate the mechanism of protection is required.
Partial replication of adiposity associations using BMI in
independent cohorts
We pursued replication of the fecal microbial adiposity
associations in a large sample of 4286 Caucasian individ-
uals from three population-based cohorts. Due to the
lack of cohorts with both visceral fat measurements and
gut microbiome data available, BMI was used as a surro-
gate measure for visceral fat. Therefore, the findings in
this section do not capture strict replication, but rather
validation of the visceral fat fecal microbial associations.
At a stringent Bonferroni threshold 8 OTUs replicated
across all cohorts, and at a more relaxed threshold 49
OTUs replicated at nominal significance in at least one
cohort with the same direction of effect as in the discov-
ery sample. The replication results included OTUs clas-
sified within Lachnospiraceae and Ruminococcaceae. A
higher relative abundance of Firmicutes has previously
been associated with obesity in some but not all studies,
and several of these studies show an increase in
Firmicutes in obese subjects [12, 53, 54]. For example,
Ruminococcus gnavus has been shown to be significantly
enriched in low microbial gene count individuals who
were prone to obesity in one study [15]. However, the
phylum Firmicutes contains more than 270 genera with
many different and diverse functions. Because changes
may occur at finer-grained taxonomic resolution, and
because the baseline abundance of different genera
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differs among human populations, opposing selection
processes at different phylogenetic levels may in part ex-
plain differing results in studies determining microbiota
differences in obesity [55, 56], including recent meta-
analyses across multiple obesity microbiota datasets [16,
57]. This difference in directional effects in genera of the
same family has been noted in animal models. Mice con-
suming a Western diet have previously been reported to
have increased levels of Eubacterium dolichum [58],
while another study has shown that mice consuming a
high-fat diet have decreased levels of Allobaculum OTUs
[59]. Both of these microbes are members of the
Erysipelotrichaceae family, and yet they show opposite
directions of effect in our data.
We observe a small number of robust associations
across all cohorts, but more than half of the findings val-
idated in at least one of the replication cohorts. The rea-
sons for the partial replication of our results are unclear
and are likely in part to capture differences in protocols,
genetics, geography, lifestyle and diet, which are difficult
to account for in full during the analysis. The American
Gut dataset used the protocols developed for the Earth
Microbiome Project [60], which are largely the same as
those used in Goodrich et al. [31], except that the
American Gut dataset is filtered to remove Gammapro-
teobacteria sequences increased following transit. FGFP
protocols are most similar to those of TUK-D and TUK-
R, however, with similar sample collection methods and
sequencing protocols. Analysis of the American Gut data
adjusted for more covariates than TUK-R, TUK-D and
FGFP, and the cohort itself included a different age
range (average 50, 21–94) and gender ratio (53 %
female). The age range and gender ratio of the FGFP
cohort were similar to those of AG (average age = 51
(21–85), 55 % female), while TUK-R was expectedly
more similar to TUK-D (average age = 57.3 (20–89),
80 % female). Additionally, the American Gut samples
were primarily from the USA (84 %), unlike the discov-
ery and replication TwinsUK samples from the UK and
the Belgian FGFP samples. The majority of the 97 OTUs
show the same direction of association in the TwinsUK
discovery, TwinsUK replication and FGFP samples, but
this is not the case in the American Gut sample results
(Additional file 5). This observation may partly reflect
potential differences in OTU associations in different
populations and geographical locations, specifically be-
tween European and American samples. Previous studies
have shown some differences at the OTU level between
countries [42, 61]. The sample collection methods also
differed between the European studies with greater
quantities collected in TUK-D, TUK-R and FGFP com-
pared to swabs in American Gut, although neither used
fixatives. These factors highlight the on-going difficulty
in replicating OTU level results between studies and
cohorts. Additional standardisation of both technical
and analytical methods will help distinguish features
common across populations, those sensitive to technical
influence and those unique to a particular region or
group.
Microbial metabolism is altered in obese individuals
Our findings of strong association between particular
microbes along with their directional effect in obesity
can provide insights into functional impacts. It has been
suggested that the dysbiosis of microbial species in
obesity is not as important as the resulting functional
dysbiosis [62]. Using the PICRUSt method to predict
metagenomes and functions, we find an enrichment of
metabolism-related KEGG functions associated with
adiposity, in particular, carbohydrate metabolism and
N-glycan biosynthesis. We see a strong positive associ-
ation between visceral fat and glyoxylate and dicarboxylate
metabolism, particularly with the genes ttdA and ttdB.
The glyoxylate cycle, a pathway that until recently was
thought to be absent in most animals [63], is able to me-
tabolise fatty acids into glucose, thus contributing to insu-
lin resistance in the event of fatty acid abundance [64].
More recently glyoxylate has been highlighted as a bio-
marker of type 2 diabetes, even as much as 3 years prior
to diagnosis of diabetes [65]. Here we show a potential
mechanistic impact of the microbial dysbiosis observed in
individuals with increased visceral fat. We cannot assess
whether the heritable microbes are driving the differences
observed in these pathways; however, it would be interest-
ing to determine the heritability of the inferred microbial
functions, particularly in future studies with metagenomic
datasets.
Host genetics influences the human fecal microbiome
and its link to central adiposity
Our new OTU heritability estimates in this larger twin
sample remain largely similar to those in the original
Goodrich et al. [31] twin-based heritability analysis re-
sults, although peak heritable OTUs are slightly differ-
ent. Comparison of the heritability results at the genus
level show that consistent estimates were obtained
across the two datasets (r = 0.67, Additional file 3: Figure
A), and these were also consistent with a recent herit-
ability analysis of the extended TwinsUK dataset [33] (r
= 0.77, Additional file 3: Figure B). The most heritable
taxon in our dataset is an OTU classified as Clostridium
perfringens (h2 = 0.42). The heritability estimate for the
most heritable OTU reported in the Goodrich et al. [31]
study, OTU 176318 assigned to Christensenellaceae (ori-
ginal heritability estimated at 0.36), remained similar in the
extended dataset, with a new heritability of 0.31. The most
heritable OTUs in our dataset were relatively frequent, be-
ing present in at least 25 % of individuals. A potential
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mechanism that underlies fecal microbial heritability is the
ability of the host genome to impact the gut environment,
for example, by altering acidity of the gut or by host con-
trol of microRNAs that can enter bacterial cells and affect
bacterial growth [66]. Therefore, the likely mechanism of
microbial heritability is host genetic manipulation of mi-
crobes [67].
The OTUs that we identified as significantly associated
with adiposity phenotypes displayed significantly greater
estimates of heritability compared to all OTUs profiled
in the gut, which therefore prompted us to test if spe-
cific human genetic variants may explain the observed
microbial heritability at these 97 adiposity-associated
OTUs. To explore how human genes could influence
these microbes in the context of obesity, we pursued host
genetic association analyses of the adiposity-associated
OTUs using a candidate gene analysis approach at host
obesity GWAS loci. The most significant genetic associ-
ation was obtained with a variant in the gene FHIT, which
encodes the fragile histidine triad protein. Significantly re-
duced FHIT gene expression levels have been reported in
cardiac tissue from obese compared to lean subjects [68].
Although this genetic variant is not an eQTL itself, it does
show moderate evidence for genetic impacts on DNA
methylation levels in adipose tissue, specifically at a CpG
site in a CpG island shore in the promoter of the FHIT
gene. Therefore, it may have an indirect impact on FHIT
adipose tissue gene expression in obesity through epigen-
etic regulation of FHIT expression. FHIT also appears to
act as a tumour suppressor in several types of cancer [69],
and its abnormal function has been linked to cancers of
the digestive tract [70]. The FHIT-associated OTU is
strongly associated with abdominal adiposity in our data,
including SFM and VFM, suggesting that it plays a role in
cardio-metabolic disease risk in the host.
Human genetic variants in or near two other genes,
ELAVL4 and TDRG1, were also significantly associated
with adiposity OTUs. Although these genes currently lack
a clear biological link to obesity, they are expressed in tis-
sues that are part of the GI tract. Furthermore, rs1433723
in TDRG1 is an interesting candidate for follow-up, as it
exhibits strong genetic influences on TDRG1 gene expres-
sion in parts of the GI tract (oesophagus mucosa). This
genetic variant also impacts TDRG1 DNA methylation
levels in adipose tissue, specifically at a CpG site in an
intra-genic CpG island in the gene body, which could
mark an alternative transcription start site. GTEx sum-
mary expression profiles of this gene correspondingly
show exon bias in expression levels across different
tissues, consistent with alternative transcript usage.
The four significantly associated host genetic variants in
FHIT, ELAVL4 and TDRG1 were not the same as the lead
SNPs for each candidate obesity locus reported in Locke
et al. [8], and are in low to moderate linkage disequlibrium
(LD) with the corresponding lead SNPs (r2 = 0.014–0.25).
This could be attributed to several reasons, including sam-
ple size and imputation differences. Compared to our
sample of 1313 twins, the sample size in Locke et al. [8] is
more than 300,000 individuals, resulting in excellent
power to detect phenotypic associations with particular
lead SNPs. There were also differences between the im-
putation strategies used by the two studies; whereas in
Locke et al. [8] SNPs were imputed to the HapMap 2
reference panel, our dataset was imputed to the 1000
Genomes reference panel. These and other factors may
impact the association of the lead SNP from Locke et al.
[8] with OTUs in this dataset.
Our heritability and host genetic association results
show that human genetic factors have a role both in
determining obesity and in influencing the host fecal
microbial composition. The strong associations that we
detect between fecal microbes and obesity phenotypes
suggest that host genetics may influence these microbial-
obesity associations. Using a candidate gene approach, we
identified host genetic variants in three obesity human loci
which show associations with adiposity-associated fecal
microbes in our dataset. These variants are promising
candidates for further follow-up studies to assess their
potential role in obesity-microbial interactions. Although
human obesity is highly heritable, human genetic variants
detected to date explain only a small proportion of the
heritability in obesity. Given our observation that the aver-
age microbial heritability is greater at the most associated
adiposity OTUs, our results are therefore consistent with
the hypothesis that a proportion of the heritability in obes-
ity may be explained by heritable fecal microbes.
Limitations and considerations
Due to the cross-sectional and observational nature of the
study, we are unable to determine causal relationships be-
tween the fecal microbiota, host genetics and visceral adi-
posity. Furthermore, to determine more robust genetic
associations, we require a much larger sample size than is
represented here. Lack of metagenomic data limits our
functional interpretation of the microbial dysbiosis ob-
served in obesity, although predictions from PICRUSt do
provide some interesting insights for further investigation.
Some research has shown that in individuals who are diet-
ing, there is an increase in Bacteroidetes and, conversely,
individuals who are over-eating show an abundance of
Firmicutes [53]. It is therefore important to know whether
the individuals in the study were calorie restricted. This is
one limitation of the present study, and future work
should focus specifically on how the interaction of diet
affects visceral fat associations with the fecal microbiome.
Other considerations that should be taken into account in
the future are stool consistency [71] and antibiotic and
other drug use [72, 73].
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Due to the novelty of visceral fat measurement and
lack of adiposity measurements other than BMI in other
microbiome datasets, we lacked true replication in inde-
pendent cohorts, which would likely have improved our
results, as would have having a better balance of genders
in discovery and replication samples.
Conclusions
We have found strong associations between fecal micro-
bial profiles with total and visceral fat, in the largest fecal
microbiota-obesity study to date using multiple mea-
sures of human adiposity, some of which are robustly
replicated. We identify novel and confirm previously
established fecal microbe associations with overall
obesity. Additionally, our study can help distinguish pro-
tective and risk microbes in human cardiovascular and
metabolic disease risk by using visceral fat as risk pheno-
type. We obtain novel high heritability estimates for vis-
ceral fat and android/gynoid ratio in a large twin sample,
and confirm previously reported heritability estimates
for other adiposity measures. Furthermore, we identify
promising host genetic variants that may influence the
interaction between the human fecal microbiome and
obesity and its metabolic consequences. Our findings
support the hypothesis that heritable microbes play a
major role in the components of adiposity that are most
relevant to cardio-metabolic disease risk.
Methods
Subjects and sample collection
All subjects included in the study were healthy volun-
teers from the TwinsUK Adult Twin Registry [48, 74].
Adiposity phenotype data were collected on the ex-
tended sample of 3666 twins (Table 1). These included
1044 monozygotic (MZ) and 789 dizygotic (DZ) pre-
dominantly female twin pairs. The sample participants
were predominantly of European descent and the aver-
age age was 63 (Table 1). Fecal microbiome data were
obtained for a subset of 1313 individuals from the sam-
ple 3666 twins. The microbiome dataset included 496
MZ, 594 DZ and 223 unrelated individuals, who were
also predominantly female and European, and the
average age was also 63 (Table 1 and Additional file 1:
Table S7). Fecal samples from all individuals followed
the same collection protocol as previously reported
[31, 33, 34]. Briefly, fecal samples were refrigerated or
kept on ice for 1–2 days prior to arriving at the la-
boratory at the Department for Twin Research, King’s
College London, at which point they were immedi-
ately stored for up to 8 weeks at −80 °C before DNA
extraction. Frozen samples were shipped to Cornell
University for DNA extraction, PCR amplification and
sequencing. The study was approved by the local
research ethics committee, and signed and written con-
sent was obtained from all participants.
Fecal microbiome profiles
This manuscript explores 16S gut microbial profiles from
a total of 1313 twin stool samples. Of these, 601 16S fecal
microbiome profiles were previously described by Good-
rich et al. [33], 671 profiles were recently published in
Jackson et al. [34] and additional 16S microbial profiles
were generated in a further 41 twin stool samples [33],
giving us altogether 1313 individuals for whom both 16S
gut microbial data and adiposity measures were available.
The sequence data for the discovery TwinsUK fecal
microbial sequence dataset used in this study are
available from the European Nucleotide Archive
(ERP006339, ERP006342, ERP015317. Sample acces-
sions can be found in Additional file 1: Table S8).
Briefly, all samples underwent the same laboratory proto-
col and data processing steps, following the quality control
procedure outlined by Goodrich et al. [33]. DNA extracted
from fecal samples underwent amplification of the V4 region
of the 16S rRNA gene using the 515F and 806R primers,
followed by 250-bp paired-end sequencing on the Illumina
MiSeq platform. Processing of sequencing and OTU pick-
ing was carried out as previously described [34]. In brief,
paired-end sequences were merged with at least a 200-bp
overlap, and those longer than 275 bp were filtered from
the dataset. The remaining sequences were analysed using
QIIME 1.7.0 (Quantitative Insights Into Microbial Ecology)
[43]. Sequences containing ambiguous or low quality reads
(Phred score ≤25) and uncorrectable barcodes were re-
moved from the dataset and open-reference OTU picking
was performed against the Greengenes May 2013 database.
OTUs not found in at least 25 % of individuals were then
discarded, and their counts were converted to relative
abundances within samples, followed by the addition of a
pseudocount (10−6) to remove zero counts. Mixed effects
models were fitted to these data to control for technical
and batch effects. The regression included sequencing run,
depth of sample sequencing and technician who extracted
and loaded the DNA for sequencing, as well as sample col-
lection method (by post or in person) as predictors with
OTU abundances as the response. Residuals from these
models were then used in subsequent downstream analyses.
The adiposity OTU and OTU candidate gene downstream
analyses also included further adjustment for covariates
such as age, gender and five long-term (10-year) summary
broad dietary profiles (see following subsection on pheno-
type data). The final dataset contained 2135 OTUs.
In estimating collapsed taxonomy quantifications,
OTUs from the complete set (including those in <25 %
of individuals) were collapsed into genera and families
based on shared taxonomic assignment. Taxa found in
fewer than 10 individuals were then discarded and the
Beaumont et al. Genome Biology  (2016) 17:189 Page 13 of 19
counts converted to relative abundances. We applied the
OTU quality control regression framework to correct for
technical covariates and batch effects as described above,
and then used the resulting residuals in subsequent
downstream analyses.
Phenotype data
Obesity phenotype data were collected during each
participant’s annual clinic visit. We explored six obesity-
related phenotypes in this work for a complete dataset
of 3666 phenotyped twins. The adiposity phenotypes
included a number of measures from total body dual-
energy X-ray absorptiometry (DXA) whole-body scan-
ning. During the DXA procedure participants were
asked to lie flat and straight while a full body scan took
place, as previously reported [75], taking measures for
percentage trunk fat and visceral fat mass (g) [32].
Visceral fat mass was calculated from one cross section
of the whole body at L4–L5, the typical location of a CT
slice. Other phenotypes collected were subcutaneous fat
mass, percentage trunk fat, BMI, android/gynoid ratio
and waist/hip ratio. Subjects were asked to remove their
shoes and height (cm) was measured using a stadi-
ometer. Weight (kg) was measured on digital scales.
Waist circumference was measured using a tape, halfway
between the lower border of the ribs and the iliac crest
in a horizontal plane. Hip circumference was measured
at the widest point over the buttocks.
Covariates for phenotypic analyses included age and
gender in all 3666 individuals and dietary profiles in 1313
individuals. We did not have detailed dietary information
at the time of fecal sample donation for this dataset; how-
ever, we had available previously collected and reported
dietary profiles [76]. Teucher et al. collected food fre-
quency questionnaires and performed a principal compo-
nent analysis on these data. The proportion of variance
explained by the first five principal components was 22 %,
and they corresponded broadly to the following approxi-
mate diets: Fruit and Veg, Traditional English, High
Alcohol, Dieting and Low Meat (see [76]). We used these
five variables as long-term stable dietary profiles in the
downstream microbiome association analyses.
Statistical analysis
To assess the evidence for association between fecal
microbiome composition and obesity-related and meta-
bolic phenotypes, we performed two principal analyses.
First, we compared microbiome OTUs and phenotypes
by fitting a linear mixed effects regression (LMER)
model using the R package lme4 [77] across all 1313 in-
dividuals. In this model the phenotype was the response
variable, and the OTU was a fixed effect predictor. Add-
itional factors included family and zygosity taken into
account as random effects, and sex, age and dietary
profiles (principal components) considered as fixed ef-
fects. Each phenotype was normalised to a standard
normal distribution prior to analysis. To assess the sig-
nificance of the associations, we compared the full re-
gression model described above to a null model that
excluded the OTU predictor using an analysis of vari-
ance (ANOVA) test in R. We report associations that
passed nominal significance (P = 0.05), as well as
those that passed a Bonferroni threshold for multiple
testing (P = 3.90 × 10−06).
Heritability, the proportion of total variance in a trait
attributed to genetics, was assessed using the ACE
model. Under the assumption that the dominance effects
are negligible, the ACE model can estimate the additive
genetic (A), common environment (C) and unique envir-
onment (E) components of the trait variance. Narrow-
sense heritabilities were estimated from the proportion
of the total phenotypic variance explained by estimated
additive genetic effect. To estimate parameters of the
ACE model, a maximum likelihood method was ap-
plied under multivariate normality assumptions using
OpenMx software [78], a structural equation model-
ling package in R. We also provide 95 % confidence
intervals for both phenotype and OTU heritability
estimates in this study.
Functional analysis was performed using PICRUSt
v1.0.0. Counts of KEGG functions were obtained and
then transformed into relative abundances. The values
were then transformed using the Hellinger transform-
ation prior to adjustment for the following technical co-
variates: sequencing run, technician who performed the
DNA extraction and technician who loaded the plate.
The functional residuals from this adjustment were then
fit into a linear mixed effects regression as predictor var-
iables, where adiposity phenotypes were the response.
Further covariates in the regression included age, sex, zy-
gosity and family structure as described above. Differential
abundance analysis was performed on the residuals using
STAMP [45], whereby a two-sided Welch’s t test was used
to test the difference in KO counts between high and
low visceral fat groups. A Benjamini-Hochberg FDR
correction [79] was applied to the association P values
from the linear mixed effects regression and the differ-
ential abundance analysis.
Host genomic analyses
Host genotype data were available in 1059 individuals from
the microbiome dataset (see Additional file 2). Briefly,
genotyping in TwinsUK was performed with a combination
of Illumina HumanHap300, HumanHap610Q, 1MDuo and
1.2MDuo 1 M chips, and genotypes were called as previ-
ously described [48]. Imputation was performed using the
IMPUTE software package (v2) [80] using as reference
panel the 1000 Genomes haplotypes (based on SHAPEIT2)
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Phase I integrated variant set release (v3, September 2013).
See Additional file 2 for further details.
In the candidate gene analysis the list of human candi-
date obesity GWAS SNP associations was obtained from
Locke et al. [8]. The reported SNPs in Locke et al. were
taken as the lead SNP, and candidate gene regions were
extended to include additional SNPs within a 25-kb re-
gion either side of the lead SNP. SNPs were included in
downstream analysis if they had a minor allele frequency
(MAF) of 5 % and an info score of more than 0.4 in our
imputed sample. Overall, there were 8876 SNPs across
97 unique genomic regions that were included in down-
stream association analyses. Host genetic association
analysis was performed using the software Genome-wide
Efficient Mixed Model Association (GEMMA) [81] at
the variants included in the 97 human obesity candidate
loci. GEMMA implements a univariate linear mixed
model to perform association tests, using a kinship
matrix to take into account twin relatedness.
DNA methylation profiles were obtained in 542 female
Caucasian twins using the Infinium HumanMethyla-
tion450 BeadChip assay (Illumina 450 k). The DNA
methylation Illumina 450 k dataset was obtained from
adipose tissue biopsies in the twins, as previously de-
scribed [48] (ArrayExpress E-MTAB-1866). DNA methy-
lation levels were first normalised using BMIQ [82], and
adjusted for covariates including age, smoking, alcohol,
zygosity, family, plate, bisulphite-sequencing (BS) con-
version efficiency and BS conversion concentration (see
Additional file 2). The resulting residuals were normal-
ised, and methylation QTL analysis was performed using
Matrix eQTL [83]. The analysis considered genetic asso-
ciation under the additive model between genetic vari-
ants at rs74331972, rs1433723, rs2480677 and 467,928
DNA methylation probes that passed quality control.
Gene expression quantitative trait locus (eQTL) results
were available from a large-scale study of human gene ex-
pression in multiple tissue samples including subcutane-
ous fat, lymphoblastoid cell lines and whole skin, derived
from 856 monozygotic (MZ) and dizygotic (DZ) female
twins from the TwinsUK cohort, as part of the MuTHER
project [47]. We interrogated the candidate SNPs for
eQTL results in adipose tissue (subcutaneous fat) using
the Genevar software [84]. The functional impact of the
candidate SNPs was also explored using GTEx results
across multiple tissues, using GTEx Analysis Release v6
(dbGaP Accession phs000424.v6.p1) [46].
Replication of obesity-microbial associations in
independent cohorts
American Gut cohort
Replication analyses were pursued in 2338 individuals
from the American Gut project (see Additional file 2).
American Gut (AG) participants were selected from
sequence rounds 1–21 (EBI: ERP012803) as Caucasian
over the age of 20 with a BMI between 18.5 and 30, and
living in the USA, UK, Australia or Canada (Additional
file 1: Table S7). Sequencing protocols of the AG
samples have previously been described [60, 85, 86].
Additionally, the fecal sample had to have at least 1000 se-
quences when picked closed reference using SortMeRNA
[87] against the August 2013 release of Greengenes [88].
AG samples were pre-processed to remove candidate
overgrowth sequences, as described elsewhere [89]. OTUs
were picked using closed reference in QIIME [43] at 97 %
using UCLUST [44] against the 97 replication OTUs, and
96 OTUs were successfully identified. Regression was per-
formed in Statsmodels [90] using a three-step model.
OTUs were power transformed and offset by 1. The power
transform was regressed to control for technical covariates
(see Additional file 2). Residuals from this were regressed
against lifestyle covariates, including age, last antibiotic
use, IBD diagnosis, flossing frequency and country. Nor-
malised BMI was regressed against the residual from the
second regression, with sex as a covariate. In the AG
BMI-OTU association results we observed that 26 associ-
ations had the same direction of effect while 18 were
nominally significant and had the same direction effect as
the TwinsUK discovery sample.
Flemish Gut Flora Project cohort
Replication analyses were pursued in 917 individuals
from the Belgian Flemish Gut Flora Project (FGFP) (see
Additional file 2), selected as Caucasians over the age of
20 with a BMI between 18.5 and 30 [17]. Prior to OTU
picking, sequencing depth was downsized to 10,000
reads per sample. OTUs were picked in QIIME [43] at
97 % using UCLUST [44] by closed reference picking
against the 97 replication OTUs, and 96 OTUs were
successfully detected in FGFP. OTU abundances were
power transformed and offset by 1. The power transform
was regressed to control for age, gender, alcohol average
consumption in the week prior to sampling and smoking
(yes/no). Normalised BMI was then regressed against the
residual from the first regression, with gender and dietary
restrictions (None/Vegetarian, Vegan, Macrobiotic/Other)
as covariates.
In the FGFP BMI-OTU association results we observed
that 83 associations had the same direction of effect while
34 were nominally significant and had the same direction
effect as the TwinsUK discovery sample.
TwinsUK replication dataset
The extended TwinsUK fecal microbiome dataset was
recently described [33] and included a set of 1031 indi-
viduals (not overlapping with the 1313 TwinsUK dis-
covery sample here) for whom both fecal microbial
profiles and BMI, but not visceral fat, were available. We
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therefore included these additional data as a third repli-
cation sample (TwinsUK (TUK-R)), where all individuals
were of European descent over the age of 20 with a BMI
between 18.5 and 30. Read data were closed-reference
clustered using the representative sequences for the rep-
lication OTUs as a reference, using UCLUST [44] at
97 % in QIIME v1.9.0 [43]. Counts for each OTU in
each individual were converted to relative abundances
by dividing by the total number of reads in the sample.
A count of 0.000001 was added to the relative abun-
dances to account for zeros, and these were then log
transformed. The transformed counts were then residua-
lised to adjust for sequencing run, collection method, per-
son who loaded the plate and person who performed the
DNA extraction. Lifestyle covariates included in down-
stream analyses matched those described for the TwinsUK
discovery sample. Altogether, 76 associations showed the
same direction of effect and 7 associations were nominally
significant in the TwinsUK replication sample.
Meta-analysis across cohorts
Random-effects meta-analysis was first performed across
the three replication samples (AG, FGFP and TUK-R). We
considered OTU-BMI results to replicate if they showed
the same direction of association with BMI in the meta-
analysis as in the discovery TwinsUK sample, and if the
significance level in the meta-analysis passed Bonferroni
adjustment for multiple testing (P = 5.15 × 10−4). We also
performed a meta-analysis across all four population
samples to identify additional OTUs at which the evidence
for association with BMI improved over the discovery
TwinsUK P value, even if they did not reach the Bonferroni
significance cut-off for replication. In each meta-analysis,
we assessed evidence for heterogeneity using Cochran’s Q
statistic and the I2 statistic [91], and only considered results
with no strong evidence for heterogeneity (Cochran’s Q
P > 0.05 and I2 < 0.75). The meta-analysis was performed in
R 3.1.2 with the R package ‘metafor’ [92] using as input beta
coefficients and standard errors from each independent
cohort.
Additional files
Additional file 1: Supplementary Tables. Table S1. OTUs showing at
least moderate (A >0.2) heritability in the extended TwinsUK 16S dataset.
Each variance component, additive genetics (A, or heritability), shared
environment (C) and unique environment (E) shown along with upper and
lower 95 % confidence intervals. Average relative abundance of the OTUs
in the overall dataset is also shown. Table S2. 149 Bonferroni-significant
OTU-adiposity associations. OTU-adiposity results are obtained from
linear mixed effects regression models and include the original results
(OTU-Adiposity) and results after adjustment for BMI (OTU-Adiposity
BMI-adjusted). We also provide the OTU heritability and average OTU
abundance in the cohort. The last two columns show the OTU results from
the within MZ twin-pair difference analyses (MZ Diff Beta), and whether the
MZ results were concordant with the linear mixed effects results. Reported
phenotypes are visceral fat (VFM), subcutaneous fat (SFM), android/gynoid
ratio (AGR), BMI, waist/hip ratio (WHR) and % trunk fat (pTF). Table S3.
Genus-level associations with adiposity, where the collapsed taxonomy OTU
genus was significantly associated with adiposity. Reported phenotypes are
visceral fat (VFM), subcutaneous fat (SFM), android/gynoid ratio (AGR) and
BMI. Table S4. Replication of TwinsUK (TUK-D) results in three independent
cohorts, the American Gut (AG), the Flemish Gut Flora Project (FGFP) and the
expanded TwinsUK dataset (TUK-R). The table lists the 97 OTUs forming 149
significant adiposity associations in TwinsUK and their association with BMI
in both the replication and discovery samples. In addition, the table outlines
the results of two meta-analyses that were performed across the studies,
the first of just the independent cohorts, and the second including the
discovery cohort. Finally, the last section of the table shows which OTUs
were replicated in at least one of the replication cohorts. Table S5. Human
genomic analyses at adiposity-related candidate host genes FHIT, TDRG1
and ELAVL4. The table shows significant genetic associations between the
adiposity-related candidate host genetic variants and adiposity-associated
OTUs. The final three columns summarize the results of the association
between the host genetic variants and DNA methylation at CpG sites
targeted by the Illumina 450 k array. DNA methylation association was
performed at the lead OTU-associated SNP in each locus; therefore,
rs1433722 was not tested (NA). Table S6. List of the 97 BMI-associated loci
reported in Locke et al. [8] that were used for analysis in this study. The
last column denotes the BMI GWAS P values from Locke et al. [8]. Table S7.
Demographics of the TwinsUK microbiome discovery sample and the
American Gut replication sample. Table S8. ENA accession IDs for samples
in this study currently available online and basic metadata. (XLSX 252 kb)
Additional file 2: Supplementary methods including expanded
methods for analyses and data collection performed within the discovery
cohort. (DOCX 168 kb)
Additional file 3: Genus-level heritability estimates between the TUK
discovery dataset and Goodrich. A) Scatterplot showing the genus-level
heritability between TUK-D and Goodrich et al. [31] (r2 = 0.67). B)
Scatterplot showing the genus-level heritability between TUK-D and
Goodrich et al. [33] (r2 = 0.76). (PDF 43 kb)
Additional file 4: Comparison of alpha diversity and human adiposity
phenotypes. Alpha diversity is measured using the Shannon metric. For
each adiposity phenotype considered in this study we present the r2 and
strength of association, and a trend line is shown in red. (PDF 693 kb)
Additional file 5: Concordance of OTU-BMI association results at the 97
OTUs between TwinsUK discovery sample and the three independent
replication cohorts. Points marked in red show no consistent effect
between the studies, while blue denotes consistent direction of association.
Blue points that are empty circles are not significant, while blue filled circles
indicate nominally significant results. A) Scatterplot between TwinsUK
discovery sample (TUK-D) and American Gut (AG). B) Scatterplot between
TUK-D and FGFP. C) Scatterplot between TUK-D and TwinsUK replication
sample (TUK-R). (PDF 146 kb)
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